Protective effect of immunosuppressive treatment before orthotopic kidney autotransplantation

Transplant Immunology

Volumn 24, Issue 2, 2011, Pages 107-112

  Cicora, Federico ^a,b,c   Lausada, Natalia ^a   Vasquez, Daniela N ^c   Cicora, Paola ^c   Guerrieri, Diego ^d   Gonzalez, Pedro ^e   Zalazar, Gustavo ^a   Stringa, Pablo ^a   Raimondi, Clemente ^a  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b HOSPITAL ALEMÁN   (Argentina)

^c Fundacion para la Investigacion y Asistencia de la Enfermedad Renal (FINAER)   (Argentina)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^e Universidad Provincial del Sudoeste   (Argentina)

Author keywords

Apoptosis; Immunosuppression; Inflammatory response; Ischemia reperfusion injury; Kidney transplant

Indexed keywords

HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; INTERLEUKIN 6; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY AUTOTRANSPLANTATION; KIDNEY ISCHEMIA; KIDNEY MEDULLA; MALE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION INJURY; SINGLE DRUG DOSE; UREA BLOOD LEVEL;

ANIMALS; APOPTOSIS; COMPLEMENT C3; CREATININE; GRAFT SURVIVAL; HEME OXYGENASE-1; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-6; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; MYCOPHENOLIC ACID; RATS; RATS, WISTAR; REPERFUSION INJURY; SIROLIMUS; TACROLIMUS; TRANSPLANTATION, AUTOLOGOUS; UREA;

EID: 78650417505     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2010.10.006     Document Type: Article

References (49)

1. Diethelm A.G., Blackstone E.H., Naftel D.C., Hudson S.L., Barber W.H., Deierhoi M.H., et al. Important risk factors of allograft survival in cadaveric renal transplantation. A study of 426 patients. Ann Surg 1988, 207:538.
2. Pascual M., Theruvath T., Kawai T., Tolkoff-Rubin N., Cosimi A.B. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002, 346:580.
3. Tilney N.L., Guttmann R.D. Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 1997, 64:945.
4. Shoskes D.A., Halloran P.F. Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol 1996, 155:1831.
5. Boros P., Bromberg J.S. New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant 2006, 6:652.
6. Halloran P., Aprile M. Factors influencing early renal function in cadaver kidney transplants. A case-control study. Transplantation 1988, 45:122.
7. Matsuda T., Yamaguchi Y., Matsumura F., Akizuki E., Okabe K., Liang J., et al. Immunosuppressants decrease neutrophil chemoattractant and attenuate ischemia/reperfusion injury of the liver in rats. J Trauma 1998, 44:475.
8. Puglisi R.N., Strande L., Santos M., Schulte G., Hewitt C.W., Whalen T.V. Beneficial effects of cyclosporine and rapamycin in small bowel ischemic injury. J Surg Res 1996, 65:115.
9. Lieberthal W., Fuhro R., Andry C., Patel V., Levine J.S. Rapamycin delays but does not prevent recovery from acute renal failure: role of acquired tubular resistance. Transplantation 2006, 82:17.
10. Lieberthal W., Fuhro R., Andry C.C., Rennke H., Abernathy V.E., Koh J.S., et al. Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Ren Physiol 2001, 281:F693.
11. Allison A.C., Eugui E.M. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 1996, 10:77.
12. Allison A.C., Eugui E.M. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 2000, 47:85.
13. Sakr M., Zetti G., McClain C., Gavaler J., Nalesnik M., Todo S., et al. The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. Transplantation 1992, 53:987.
14. Sakr M.F., Hassanein T.I., Zetti G.M., Van Thiel D.H. FK 506 ameliorates the hepatic injury associated with ischemia. Life Sci 1990, 47:687.
15. Ventura C.G., Coimbra T.M., de Campos S.B., de Castro I., Yu L., Seguro A.C. Mycophenolate mofetil attenuates renal ischemia/reperfusion injury. J Am Soc Nephrol 2002, 13:2524.
16. Lui S.L., Chan K.W., Tsang R., Yung S., Lai K.N., Chan T.M. Effect of rapamycin on renal ischemia-reperfusion injury in mice. Transpl Int 2006, 19:834.
17. Yang C.W., Ahn H.J., Han H.J., Kim W.Y., Li C., Shin M.J., et al. Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. Transplantation 2001, 72:1753.
18. Lin A., Sekhon C., Sekhon B., Smith A., Chavin K., Orak J., et al. Attenuation of ischemia-reperfusion injury in a canine model of autologous renal transplantation. Transplantation 2004, 78:654.
19. Richer J.P., Gibelin H., Planet M., Bardou A., Ben Amor I., Germonville T., et al. Ischemia-reperfusion injury is associated with inflammatory cell infiltration: evaluation in a pig kidney autotransplant model. Transplant Proc 2000, 32:482.
20. Tahara M., Nakayama M., Jin M.B., Fujita M., Suzuki T., Taniguchi M., et al. A radical scavenger, edaravone, protects canine kidneys from ischemia-reperfusion injury after 72hours of cold preservation and autotransplantation. Transplantation 2005, 80:213.
21. Zhang Y., Ma Q. The enhancement of cellular cAMP with olprinone protects autotransplanted rat kidney against cold ischemia-reperfusion injury. Transplant Proc 2006, 38:1580.
22. Du C., Guan Q., Yin Z., Masterson M., Zhong R., Jevnikar A.M. Renal tubular epithelial cell apoptosis by Fas-FasL-dependent self-injury can augment renal allograft injury. Transplant Proc 2003, 35:2481.
23. Land W.G. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 2005, 79:505.
24. Serteser M., Koken T., Kahraman A., Yilmaz K., Akbulut G., Dilek O.N. Changes in hepatic TNF-alpha levels, antioxidant status, and oxidation products after renal ischemia/reperfusion injury in mice. J Surg Res 2002, 107:234.
25. Bonventre J.V., Zuk A. Ischemic acute renal failure: an inflammatory disease?. Kidney Int 2004, 66:480.
26. Kimizuka K., Nakao A., Nalesnik M.A., Demetris A.J., Uchiyama T., Ruppert K., et al. Exogenous IL-6 inhibits acute inflammatory responses and prevents ischemia/reperfusion injury after intestinal transplantation. Am J Transplant 2004, 4:482.
27. Patel N.S., Chatterjee P.K., Di Paola R., Mazzon E., Britti D., De Sarro A., et al. Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exp Ther 2005, 312:1170.
28. Nikolova P.N., Ivanova M.I., Mihailova S.M., Myhailova A.P., Baltadjieva D.N., Simeonov P.L., et al. Cytokine gene polymorphism in kidney transplantation-impact of TGF-beta 1, TNF-alpha and IL-6 on graft outcome. Transpl Immunol 2008, 18:344.
29. Sacks S.H., Zhou W. Locally produced complement and its role in renal allograft rejection. Am J Transplant 2003, 3:927.
30. Leonard M., Ryan M.P., Watson A.J., Schramek H., Healy E. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells. Kidney Int 1999, 56:1366.
31. Thurman J.M., Royer P.A., Ljubanovic D., Dursun B., Lenderink A.M., Edelstein C.L., et al. Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury. J Am Soc Nephrol 2006, 17:707.
32. Zheng X., Zhang X., Sun H., Feng B., Li M., Chen G., et al. Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes. Transplantation 2006, 82:1781.
33. Dong X., Swaminathan S., Bachman L.A., Croatt A.J., Nath K.A., Griffin M.D. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int 2007, 71:619.
34. Donnahoo K.K., Shames B.D., Harken A.H., Meldrum D.R. Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 1999, 162:196.
35. Hsu H., Xiong J., Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995, 81:495.
36. Peralta Soler A., Mullin J.M., Knudsen K.A., Marano C.W. Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. Am J Physiol 1996, 270:F869.
37. Fuller T.F., Freise C.E., Serkova N., Niemann C.U., Olson J.L., Feng S. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 2003, 76:1594.
38. Yang B., Jain S., Ashra S.Y., Furness P.N., Nicholson M.L. Apoptosis and caspase-3 in long-term renal ischemia/reperfusion injury in rats and divergent effects of immunosuppressants. Transplantation 2006, 81:1442.
39. Serr F., Lauer H., Armann B., Ludwig S., Thiery J., Fiedler M., et al. Sirolimus improves early microcirculation, but impairs regeneration after pancreatic ischemia-reperfusion injury. Am J Transplant 2007, 7:48.
40. Yang B., Jain S., Pawluczyk I.Z., Imtiaz S., Bowley L., Ashra S.Y., et al. Inflammation and caspase activation in long-term renal ischemia/reperfusion injury and immunosuppression in rats. Kidney Int 2005, 68:2050.
41. Dinarello C.A., Dempsey R.A., Allegretta M., LoPreste G., Dainiak N., Parkinson D.R., et al. Inhibitory effects of elevated temperature on human cytokine production and natural killer activity. Cancer Res 1986, 46:6236.
42. Yem A.W., Tomasselli A.G., Heinrikson R.L., Zurcher-Neely H., Ruff V.A., Johnson R.A., et al. The Hsp56 component of steroid receptor complexes binds to immobilized FK506 and shows homology to FKBP-12 and FKBP-13. J Biol Chem 1992, 267:2868.
43. Wagner M., Cadetg P., Ruf R., Mazzucchelli L., Ferrari P., Redaelli C.A. Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts. Kidney Int 2003, 63:1564.
44. Goncalves G.M., Cenedeze M.A., Feitoza C.Q., Wang P.M., Bertocchi A.P., Damiao M.J., et al. The role of heme oxygenase 1 in rapamycin-induced renal dysfunction after ischemia and reperfusion injury. Kidney Int 2006, 70:1742.
45. Valentin J.F., Bruijn J.A., Paul L.C. Donor treatment with mycophenolate mofetil: protection against ischemia-reperfusion injury in the rat. Transplantation 2000, 69:344.
46. Shihab F.S., Bennett W.M., Andoh T.F. Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation. Transplantation 2009, 87:326.
47. Reutzel-Selke A., Zschockelt T., Denecke C., Bachmann U., Jurisch A., Pratschke J., et al. Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors. Transplantation 2003, 75:1786.
48. Kunzendorf U., Hohenstein B., Oberbarnscheid M., Muller E., Renders L., Schott G.E., et al. Duration of donor brain death and its influence on kidney graft function. Am J Transplant 2002, 2:292.
49. Morariu A.M., Schuurs T.A., Leuvenink H.G., van Oeveren W., Rakhorst G., Ploeg R.J. Early events in kidney donation: progression of endothelial activation, oxidative stress and tubular injury after brain death. Am J Transplant 2008, 8:933.